Companies: 10,795·Total market cap: $144.5T
Stryker Corporation

Stryker Corporation

SYKNYSEHealthcare● Active
$304.15
$-1.51(-0.49%)
Market Cap$116.6B
P/E Ratio
52W High$404.87
52W Low$281
Overview

Stryker Corporation (SYK) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

SYK · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$4.10B -8.7% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$4.01B
cashAndCashEquivalents
Short-Term Investments
$89.0M
shortTermInvestments
YoY Change vs Prior Year
-8.7%
vs prior fiscal year
Latest Quarter
$2.96B
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$4.10BCash on Hand
Total Debt$14.86BTotal Debt
Net Cash / Net Debt−$10.76BNet Debt Position
Cash vs Debt Ratio
Cash 22%Debt 78%

Stryker Corporation carries a net debt position of $10.76B. Total debt ($14.86B) exceeds cash on hand ($4.10B). Stryker Corporation cash vs debt ratio: 22% cash / 78% debt.

Net Cash = Cash & ST Investments − Total Debt$4.10B$14.86B = −$10.76B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
SYK annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$4.10B-8.7%
Dec 31, 2024$4.49B+47.2%
Dec 31, 2023$3.05B+58.4%
Dec 31, 2022$1.93B-36.1%
Dec 31, 2021$3.02B-0.2%
SYK cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.7%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Stryker Corporation
Stryker CorporationYOU
SYK
$4.10B3.5%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Stryker Corporation (SYK) cash on hand as of December 31, 2025 is $4.10B, comprising $4.01B in cash and cash equivalents (CCE) plus $89.0M in short-term investments — reported as Stryker Corporation cash and short-term investments on the balance sheet (10-K filing). Also referred to as Stryker Corporation cash reserves or cash position.

Stryker Corporation annual cash on hand history shows decreased -8.7% in 2025: decreased -8.7% in 2025. Stryker Corporation cash reserves in 2025 reflect the company's capital allocation strategy.

Stryker Corporation carries total debt of $14.86B against cash of $4.10B, resulting in a net debt position of -$10.76B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Frequently asked questions

SYK cash on hand · 5 questions

As of December 31, 2025, Stryker Corporation (SYK) has $4.10B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $4.01B in cash and cash equivalents (CCE) plus $89,000,000 in short-term investments. Latest quarter (March 31, 2026): $2.96B. Data sourced from the annual 10-K filing via FMP.

SYK cash on handSYK cash reservesSYK cash 2025how much cash does SYK have

Source: FMP /balance-sheet-statement · US GAAP · Stryker Corporation · Stryker Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025